Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 10, 2018 (8 years ago)

Cyclosporine 1% Human Eye Drops

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Process Controls

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Cyclosporine 1% Human Eye Drops, Westlab Pharmacy, Inc., Gainesville, FL 32607 NDC 10002-2776-92

Affected NDC 10002-2776-92

Compare with the code on your package — it is the most precise check available.

Drug: Cyclosporine Category: Eye Drops & Ophthalmic

Recalling firm
Westlab Pharmacy, Inc. dba Westlab Pharmacy
NDC code
10002-2776-92
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0091-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Cyclosporine recalls

See all
Class I · High risk

SANDIMMUNE Oral Solution

Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals

Ongoing Failed specification Novartis Pharmaceuticals Corporation NDC 0078-0110-22 D-0144-2024
Class I · High risk

SANDIMMUNE Oral Solution

Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals.

Ongoing Failed specification Novartis Pharmaceuticals Corp. NDC 0078-0110-22 D-1174-2023

Other recalls by Westlab Pharmacy, Inc. dba Westlab Pharmacy

All 2018 recalls
Class II · Moderate risk

ADAA Cataract Drops

Lack of Process Controls

Terminated cGMP deviation Westlab Pharmacy, Inc. dba Westlab Pharmacy NDC 10002-2579-05 D-0090-2019
Class II · Moderate risk

Alprostadil 500 mcg/mL Injectable

Incorrect Product Formulation

Terminated Other Westlab Pharmacy, Inc. dba Westlab Pharmacy NDC 10002-7335-00 D-0089-2019